Your browser doesn't support javascript.
Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
Haddad, Anneke; Janda, Ales; Renk, Hanna; Stich, Maximilian; Frieh, Pauline; Kaier, Klaus; Lohrmann, Florens; Nieters, Alexandra; Willems, Anna; Huzly, Daniela; Dulovic, Alex; Schneiderhan-Marra, Nicole; Jacobsen, Eva-Maria; Fabricius, Dorit; Zernickel, Maria; Stamminger, Thomas; Bode, Sebastian F N; Himpel, Theda; Remppis, Jonathan; Engel, Corinna; Peter, Andreas; Ganzenmueller, Tina; Hoffmann, Georg Friedrich; Haase, Bettina; Kräusslich, Hans-Georg; Müller, Barbara; Franz, Axel R; Debatin, Klaus-Michael; Tönshoff, Burkhard; Henneke, Philipp; Elling, Roland.
  • Haddad A; Center for Pediatrics and Adolescent Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Janda A; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Germany.
  • Renk H; University Children's Hospital Tuebingen, Tuebingen, Germany.
  • Stich M; Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
  • Frieh P; Center for Pediatrics and Adolescent Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Kaier K; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
  • Lohrmann F; Center for Pediatrics and Adolescent Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; IMM-PACT Clinician Sc
  • Nieters A; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Willems A; Center for Pediatrics and Adolescent Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Huzly D; Institute of Virology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.
  • Dulovic A; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
  • Schneiderhan-Marra N; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
  • Jacobsen EM; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Germany.
  • Fabricius D; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Germany.
  • Zernickel M; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Germany.
  • Stamminger T; Institute of Virology, Ulm University Medical Center, Ulm, Germany.
  • Bode SFN; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Germany.
  • Himpel T; University Children's Hospital Tuebingen, Tuebingen, Germany.
  • Remppis J; University Children's Hospital Tuebingen, Tuebingen, Germany.
  • Engel C; Centre for Paediatric Clinical Studies, University Children's Hospital Tübingen, Tübingen, Germany.
  • Peter A; Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.
  • Ganzenmueller T; Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
  • Hoffmann GF; Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
  • Haase B; Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
  • Kräusslich HG; Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
  • Müller B; Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
  • Franz AR; University Children's Hospital Tuebingen, Tuebingen, Germany; Centre for Paediatric Clinical Studies, University Children's Hospital Tübingen, Tübingen, Germany.
  • Debatin KM; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Germany.
  • Tönshoff B; Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
  • Henneke P; Center for Pediatrics and Adolescent Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Elling R; Center for Pediatrics and Adolescent Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Electronic address: r
EBioMedicine ; 84: 104245, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-2041662
ABSTRACT

BACKGROUND:

Long COVID in children and adolescents remains poorly understood due to a lack of well-controlled studies with long-term follow-up. In particular, the impact of the family context on persistent symptoms following SARS-CoV-2 infection remains unknown. We examined long COVID symptoms in a cohort of infected children, adolescents, and adults and their exposed but non-infected household members approximately 1 year after infection and investigated clustering of persistent symptoms within households.

METHODS:

1267 members of 341 households (404 children aged <14 years, 140 adolescents aged 14-18 years and 723 adults) were categorized as having had either a SARS-CoV-2 infection or household exposure to SARS-CoV-2 without infection, based on three serological assays and history of laboratory-confirmed infection. Participants completed questionnaires assessing the presence of long COVID symptoms 11-12 months after infection in the household using online questionnaires.

FINDINGS:

The prevalence of moderate or severe persistent symptoms was statistically significantly higher in infected than in exposed women (36.4% [95% CI 30.7-42.4%] vs 14.2% [95% CI 8.7-21.5%]), infected men (22.9% [95% CI 17.9-28.5%] vs 10.3% [95% CI 5.8-16.9%]) and infected adolescent girls (32.1% 95% CI 17.2-50.5%] vs 8.9% [95%CI 3.1-19.8%]). However, moderate or severe persistent symptoms were not statistically more common in infected adolescent boys aged 14-18 (9.7% [95% CI 2.8-23.6%] or in infected children <14 years (girls 4.3% [95% CI 1.2-11.0%]; boys 3.7% [95% CI 1.1-9.6%]) than in their exposed counterparts (adolescent boys 0.0% [95% CI 0.0-6.7%]; girls < 14 years 2.3% [95% CI 0·7-6·1%]; boys < 14 years 0.0% [95% CI 0.0-2.0%]). The number of persistent symptoms reported by individuals was associated with the number of persistent symptoms reported by their household members (IRR=1·11, p=·005, 95% CI [1.03-1.20]).

INTERPRETATION:

In this controlled, multi-centre study, infected men, women and adolescent girls were at increased risk of negative outcomes 11-12 months after SARS-CoV-2 infection. Amongst non-infected adults, prevalence of negative outcomes was also high. Prolonged symptoms tended to cluster within families, suggesting family-level interventions for long COVID could prove useful.

FUNDING:

Ministry of Science, Research and the Arts, Baden-Württemberg, Germany.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adolescent / Adult / Child / Female / Humans / Male Language: English Journal: EBioMedicine Year: 2022 Document Type: Article Affiliation country: J.ebiom.2022.104245

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adolescent / Adult / Child / Female / Humans / Male Language: English Journal: EBioMedicine Year: 2022 Document Type: Article Affiliation country: J.ebiom.2022.104245